Zaid Fadul, MD, FS, FAAFP, introduces the Nolla Derm app, what it might mean for pharmacists and their patients, and where AI prescribing is headed in the future.
|Articles|November 8, 2004
IDSA warns: New antibiotics needed ASAP
Once referred to as "miracle drugs" for their ability to eradicate infection and save countless lives, antibiotics are losing their battle against resistant organisms, and no fresh supply of novel drugs exists. Unless antibiotic research and development is reinvigorated soon, a public health crisis is imminent.
Advertisement
Advertisement
Related to this article
Among a collection of patients across 15 pharmacies, researchers assessed acceptability and satisfaction with pharmacist-led clinical services.
From expert sources and recent data updates to a look at cases amid the ongoing respiratory virus season, this is an updated look at 2026 measles outbreaks in the US.
Zaid Fadul, MD, FS, FAAFP, joins for part 2 to discuss what greater adoption of AI across health care ecosystems might mean for pharmacists, patients, and more.
For pharmacies competing with CVS and relying on Caremark to serve patients, the prospect of those businesses operating under separate ownership is significant.
Erin Albert of Mark Cuban Cost Plus Drugs explains how the Team Cuban Card offers transparent pricing and fair pay for independent pharmacies.
An abstract from the American Heart Association's Scientific Sessions 2026 reveals the continuous expansion of the GLP-1 medication class.
Matthew Crawford, PhD, of the University of Virginia, and Mario Danek of Qnovia explain what pharmacists can do now and what may come next.
Advertisement
Advertisement
Trending on Drug Topics
1
Team Cuban Card Includes Transparent Pricing for Cash Patients
2
CVS Plans to Split Off Its Retail Pharmacies, Keeping Specialty Operations
3
The Future of HIV PrEP and One Step to Take Tomorrow
4
How AI Prescribing Could Transform the Pharmacist’s Role in Health Care
5